Sign in

NCT06361524Enrolling by invitation

Gut Microbiome Profiling in Patients With Chronic Heart Failure

Longitudinal Gut Microbiome and Host Multi-omic Profiling in Patients With Chronic Heart Failure

Source: ClinicalTrials.gov · Last updated 16 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this observational study is to learn about the composition and function of the gut microbiome in adults with chronic heart failure with reduced ejection fraction. The main questions the study aims to answer are: 1. How does the gut microbiome and its interactions with the host change over time in adults with chronic heart failure? 2. How do these changes relate to heart failure disease severity and complications?

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
150 (estimated)
First submitted
5 Apr 2024
Start date
1 Aug 2018
Primary completion date
Dec 2028
Lead sponsor
Stanford University
NCT number
NCT06361524

What you commit to

  • Study type: Observational
  • Planned participants: 150
  • From 1 Aug 2018 to the primary completion date, Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current or recent (within 4 weeks) use of systemic antibiotics, commercial probiotics, immunosuppressive or immunomodulatory medications

Other illness

  • Treated diabetes
  • Advanced kidney disease
  • Significant gastrointestinal disease including any history of inflammatory bowel disease
  • History of extensive bowel resection
  • Active malignancy or systemic chemotherapy within the past 12 months
  • Active infection

Other

  • Cirrhosis
  • Pregnancy/lactation

Who the study is looking for

  • Heart failure with reduced ejection fraction (left ventricular ejection fraction less than 50%)
  • Non-ischemic cardiomyopathy
  • Body mass index (BMI) 18-40 kg/m2

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Stanford University
Coordinator of this site? Confirm its status
StanfordUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.